Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

17 trials with published results (10%)

Research Maturity

63 completed trials (36% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.4%

6 terminated out of 176 trials

Success Rate

91.3%

+4.7% vs benchmark

Late-Stage Pipeline

11%

19 trials in Phase 3/4

Results Transparency

27%

17 of 63 completed with results

Key Signals

17 with results91% success

Data Visualizations

Phase Distribution

70Total
Not Applicable (37)
P 1 (8)
P 2 (6)
P 3 (13)
P 4 (6)

Trial Status

Completed63
Recruiting46
Unknown34
Not Yet Recruiting11
Active Not Recruiting8
Terminated6

Trial Success Rate

91.3%

Benchmark: 86.6%

Based on 63 completed trials

Clinical Trials (176)

Showing 20 of 20 trials
NCT05302271Phase 1Recruiting

Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia

NCT04294771Recruiting

JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors

NCT07814118Enrolling By Invitation

Multimodal Physiologic State Intelligence Study

NCT07491237Recruiting

RHYthm and Myocardial Function Relationship Evaluation in Heart Diseases

NCT07804394Not ApplicableNot Yet Recruiting

Procedural Endpoint in Left Bundle Branch Area Pacing: Conduction System Capture Versus LV Septal Capture

NCT07766135Recruiting

Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis

NCT07116473Phase 3Not Yet Recruiting

To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

NCT06610019Recruiting

Cardiovascular Multimodality Imaging Study

NCT06080074Phase 2Recruiting

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

NCT06563895Phase 3Recruiting

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

NCT05890716RecruitingPrimary

AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

NCT05034432Phase 4Recruiting

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

NCT02432092RecruitingPrimary

Pediatric Cardiomyopathy Mutation Analysis

NCT07656779Phase 1Not Yet RecruitingPrimary

Human Mass Balance Study of [¹⁴C]HRS-1893

NCT04737265Phase 1Completed

Pilot Study of an NTproBNP Guided Strategy of Cardioprotection

NCT06977217Active Not RecruitingPrimary

Factors Associated With Response to Cardiac Resynchronization Therapy in Heart Failure Patients With Non-LBBB ECG Pattern

NCT07618780Not ApplicableNot Yet Recruiting

Stereotactic Radioablation as First-Line Therapy for Scar-Related Ventricular Tachycardia

NCT06893731CompletedPrimary

Healthcare Utilization and Costs Among Hospitalized Patients With Cardiomyopathy

NCT04641416Recruiting

Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps

NCT07560891Not ApplicableNot Yet Recruiting

LBBAP vs. CS Pacing for CRT in Permanent Atrial Fibrillation and Heart Failure (SYNC-AF)

Scroll to load more

Research Network

Activity Timeline